ATXS
Astria Therapeutics, Inc.
$12.58+0.08 (0.64%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Astria Therapeutics, Inc. (ATXS) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
8 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-12 | 2025-06-11 | Cole Hugh M | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-11 | Callori Fred | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-11 | Bate Kenneth | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-11 | Violin Jonathan | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-11 | Agarwal Sunil | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-11 | Beck Joanne T. | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-11 | Kishbauch Michael D | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |
| 2025-06-12 | 2025-06-11 | Lapointe Anthony Gregg | Director | Award | 26,550 | $0.00 | $0 | N/A | N/A |